James Fulton, MD

• National Jewish Health/University of Colorado, Denver, CO
  Allergy Immunology Fellowship, 07/01/2014-06/30/2016
• Creighton University School of Medicine, Omaha, NE
  Internal Medicine Residency, 07/01/2011-06/30/2014
  Doctor of Medicine, 08/01/2007-05/01/2011
• University of California, San Diego
  Master of Science in Biological Sciences (Emphasis in Molecular Immunology)
  01/01/2004-07/01/2007
  Thesis Title: The Role of Lymphotoxin and LIGHT Signaling in Regards to Toll-Like Receptor Gene Expressio
  
  Bachelor of Science in Animal Physiology and Neuroscience with a minor in Sociology
  09/01/2000-12/01/2004

• Asthma and Allergy Associates, 09/03/2019-present
• Allergy Partners of Northern Colorado, 09/01/2016-08/30/2019
• Colorado State University Allergy Department, 09/01/2017-05/08/2019

• American Board of Allergy and Immunology, 473 score, 09/01/2016
• American Board of Internal Medicine, 488 score, 08/01/2014
• USMLE Step 3, 217 score, 06/01/2012
• USMLE Step 2 Clinical Skills, pass, 02/01/2011
• USMLE Step 2 Clinical Knowledge, 221 score, 09/01/2010
• USMLE Step 1, 222 score, 06/01/2009

• National Jewish Health, Allergy and Immunology Department, Rafeul Alam, MD, PhD

Worked on a project elucidating the role type-2 innate lymphocyte cells may play in steroid resistant asthma and Aspirin-exacerbated respiratory disease. 

05/01/2015-06/30/2016

• Creighton University School of Medicine, Biomedical Sciences, Devendra Agrawal, PhD

Worked on a project concerning Th9 cells and their contribution to the pathogenesis of asthma. 

04/01/2013-06/30/2013

• La Jolla Institute for Allergy and Immunology (LIAI), Department of Molecular Immunology, Carl Ware, PhD and Chris Benedict, PhD

Lab technician and research assistant for a project concerning the time dependent immune response cells to cytomegalovirus. 

06/01/2008-07/30/2008

• LIAI, President and Scientific Director Mitchell Kronenberg, PhD

Acted as the institute’s appointed real-time polymerase chain reaction field-expert, assisting fellow scientists with system trainings and experiment preparations. 

01/01/2007-07/01/2007

• LIAI, Department of Molecular Immunology, Carl Ware, PhD and Chris Benedict, PhD

Lab technician and research assistant for a project regarding type-I interferon response to cytomegalovirus and an independent project culminating into a MS thesis. 

01/01/2004—7/01/2007

• Fellows-In-Training Travel Scholarship, AAAAI Annual Meeting, 03/01/2016
• Fellows-In-Training Trivia Bowl Finalist, ACAAI Annual Meeting, 11/01/2015
• Fellows-In-Training Travel Scholarship, ACAAI Annual Meeting, 11/01/2015
• Fellows-In-Training Travel Scholarship, Aspen Allergy Annual Conference, 07/01/2015 
• Fellows-In-Training Travel Scholarship, AAAAI Annual Meeting, 03/01/2015
• Fellows-In-Training Travel Scholarship, ACAAI Annual Meeting, 11/01/2014
• Chrysalis Project Grant Award, AAAAI Annual Meeting, 03/01/2011
• Clinical Allergy and Immunology, course honors, 4^th year medical student, 07/01/2010

• 07/01/2014-present: American Academy of Allergy, Asthma and Immunology
• 07/01/2014-present: American College of Allergy, Asthma and Immunology
• 07/01/2014-present: Colorado Asthma and Allergy Society

• Schneider K, Loewendorf A, De Trez C, Fulton J, Rhode A, Shumway H, Ha S, Patterson G, Pfeffer K, Nedospasov SA, Ware CF, and Benedict CA. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe. 2008 Feb 14;3(2):67-76

• De Trez C, Schneider K, Potter K, Droin N, Fulton J, Norris PS, Ha SW, Fu YX, Murphy T, Murphy KM, Pfeffer K, Benedict CA, and Ware CF. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol. 2008 Jan 1;180(1):238-48

• De Trez C, Fukuyama S, Jacquin C, Fulton J, Schneider K, Norris P, Nedospasov S, Pfeffer K, and Ware CF. Lymphoid Tissue Inducer Cells Control CD8α- Dendritic Cell Homeostasis via the Lymphotoxin-β Receptor Pathway. Submitted to PNAS, 04/01/2008 

• Singla A, Fulton J, Agrawal V, and Tadros M. Lymphoma Presenting as Hypercalcemia and Normalization of Parathormone in a Patient with Underlying Secondary Hyperparathyroidism. Presented at Society of General Internal Medicine Annual Meeting by Dr Singla, Orlando, FL. 05/01/2012

• Fulton J, Bansal O, and Parr S. Subtle Atypical Symptoms in a Complicated Case of Thyrotoxicosis. Presented at Nebraska ACP annual poster competition, Omaha, NE. 10/01/2011

• De Trez C, Schneider K, Potter K, Droin N, Fulton J, Norris PS, Ha SW, Fu YX, Murphy T, Murphy KM, Pfeffer K, Benedict CA, and Ware CF. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. Assisted Dr De Trez with presentation at International TNF Conference, Asilomar, CA. 05/01/2007

• Eosinophilic Granulomatous Polyangiitis: A Case Presentation. Department Lecture, National Jewish Health, Denver, CO. 09/01/2015

• Granulomatous Lymphocytic Interstitial Lung Disease in CVID: A Case Presentation. Department Lecture, National Jewish Health, Denver, CO. 03/01/2015

• Mannose Binding Lectin Deficiency: A Case Presentation. Department Lecture, National Jewish Health, Denver, CO. 10/01/2014

• Acute Infective Endocarditis: A Case Presentation. Multidisciplinary Conference Lecture, Creighton University School of Medicine, Omaha, NE. 10/01/2010

• The Role of Lymphotoxin and LIGHT Signaling in Regards to Toll-Like Receptor Gene Expression. Thesis Defense, UCSD, La Jolla, CA. 07/01/2007